VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $297,000 | +20.7% | 12,111 | -0.9% | 0.00% | +33.3% |
| Q2 2016 | $246,000 | -87.1% | 12,225 | +13.9% | 0.00% | -90.9% |
| Q3 2015 | $1,914,000 | -47.0% | 10,729 | -34.0% | 0.03% | -45.9% |
| Q2 2015 | $3,613,000 | -4.6% | 16,264 | -14.7% | 0.06% | -7.6% |
| Q1 2015 | $3,787,000 | -23.6% | 19,068 | -44.9% | 0.07% | -29.0% |
| Q4 2014 | $4,954,000 | +4.9% | 34,616 | -3.8% | 0.09% | -2.1% |
| Q3 2014 | $4,721,000 | -44.0% | 35,989 | -46.2% | 0.10% | -21.5% |
| Q2 2014 | $8,434,000 | +11.4% | 66,870 | +16.4% | 0.12% | +3.4% |
| Q1 2014 | $7,572,000 | +7.1% | 57,440 | -4.6% | 0.12% | +0.9% |
| Q4 2013 | $7,071,000 | +9.1% | 60,232 | -3.0% | 0.12% | -2.5% |
| Q3 2013 | $6,479,000 | +28.9% | 62,101 | +6.3% | 0.12% | +19.0% |
| Q2 2013 | $5,028,000 | – | 58,412 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |